Diagnos IncOTCQB:DGNOFView on Canadian Exchange
- LAST PRICE0.2051
- TODAY'S CHANGE (%)-0.0037 (-1.7601%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.2065 / 0.2088
- Day Range
- 52 Week Range
- Volume48,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DGNOF |
|---|---|---|
| 10:26 ET | 3000 | 0.2065 |
| 10:32 ET | 5000 | 0.2028 |
| 10:48 ET | 5000 | 0.2023 |
| 11:02 ET | 5000 | 0.2064 |
| 11:06 ET | 10000 | 0.20215 |
| 11:20 ET | 5000 | 0.20575 |
| 01:32 ET | 5000 | 0.2011 |
| 02:36 ET | 5000 | 0.206 |
| 03:56 ET | 5000 | 0.205125 |
Apr 16, 2024
Apr 12, 2024
AI & Technology Hybrid Investor Conference Agenda: Presentations Now Available for Online Viewing, from 10:07AM ET on Friday Apr 12, 2024 by Dow Jones
10:07AM ET on Friday Apr 12, 2024 by Dow Jones
Apr 9, 2024
AI & Technology Hybrid Investor Conference Presented by Water Tower Research Agenda Announced for April 10 and 11, from 10:26AM ET on Tuesday Apr 09, 2024 by Dow Jones
10:26AM ET on Tuesday Apr 09, 2024 by Dow JonesDIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th, from 10:10AM ET on Tuesday Apr 09, 2024 by Dow Jones
10:10AM ET on Tuesday Apr 09, 2024 by Dow JonesDIAGNOS inc. to Present at the AI & Technology Hybrid Investor Conference April 11th, from 8:35AM ET on Tuesday Apr 09, 2024 by Dow Jones
8:35AM ET on Tuesday Apr 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Diagnos Inc | 21.5M | 0.0x | --- |
Company Information
DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. Its geographical areas include Canada, the United States, Saudi Arabia, Mexico, Costa Rica and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.
Contact Information
- Headquarters
- 7005 Taschereau Blvd Suite 340BROSSARD, QC, Canada J4Z 1A7
- Phone
- 450-678-8882
- Fax
- 450-678-8882
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $21.5M |
|---|---|
Revenue (TTM) | $196.5K |
Shares Outstanding | 76.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.42 |
EPS | $-0.04 |
Book Value | $-0.03 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 109.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,310.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
